The authors reply

Pediatric Pulmonology

Volumn 49, Issue 12, 2014, Pages 1256-1257

  Bakker, Marije ^a   Borsboom, Gerard ^b   Tiddens, Harm A ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL DECISION MAKING; CYSTIC FIBROSIS; FORCED EXPIRATORY FLOW; FORCED VITAL CAPACITY; HUMAN; LETTER; LUNG DISEASE; LUNG FLOW VOLUME CURVE; LUNG FUNCTION; OUTCOME ASSESSMENT; SMALL AIRWAY DISEASE; SPIROMETRY; FEMALE; MALE; PATHOPHYSIOLOGY;

CYSTIC FIBROSIS; FEMALE; HUMANS; MALE; SPIROMETRY;

EID: 84911981843     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.22992     Document Type: Letter

References (5)

1. Quan JM, Tiddens H A WM, Sy J, McKenzie SG, Montgomery MD, Robinson PJ, Wohl ME, Konstan MW, Pulmozyme Early Intervention Trial Study Group. A two-year randomized, placebo controlled trial of dornase alfa in young cystic fibrosis patients with mild lung function abnormalities. J Pediatr 2001;139:813-820.
2. Tiddens H A WM. Detecting early structural lung damage in cystic fibrosis. Pediatr Pulmonol 2002;34:228-231.
3. van der Giessen LJ, De Jongste JC, Gosselink R, Hop W C J, Tiddens H A WM. RhDNase before airway clearance therapy improves airway patency in children with CF. Pediatric Pulmonology 2006 2007;42:624-630.
4. Bakker EM, Volpi S, Salonini E, van der Wiel EC, Sintnicolaas C, Hop W C J, Assael BM, Merkus PJ, Tiddens HA. Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation. Eur Respir J 2011;38:1328-1335.
5. Tiddens HA, Stick SM, Davis S. Multi-modality monitoring of cystic fibrosis lung disease: the role of chest computed tomography. Paediatr Respir Rev 2013; pii: #nS1526-0542 (13) 00076-6. doi: 10.1016/j.prrv. 2013.05.003. [Epub ahead of print]